C - Chemistry – Metallurgy – 07 – C
Patent
C - Chemistry, Metallurgy
07
C
C07C 233/43 (2006.01) A61K 31/165 (2006.01) A61P 11/00 (2006.01) C07C 209/16 (2006.01) C07C 213/04 (2006.01) C07C 215/30 (2006.01)
Patent
CA 2493128
The invention provides a crystalline salt form of a novel .beta.2 adrenergic receptor agonist. The invention also provides pharmaceutical compositions comprising the crystalline form, formulations containing the pharmaceutical compositions, methods of using the crystalline salt form to treat diseases associated with .beta.2 adrenergic receptor activity, and processes useful for preparing such a crystalline compound.
L'invention concerne une forme de sel cristallin d'un agoniste de récepteur .beta.2-adrénergique. Elle concerne aussi des compositions pharmaceutiques contenant cette forme cristalline, des formulations contenant les compositions pharmaceutiques, des méthodes d'utilisation de la forme de sel cristallin afin de traiter des maladies associées à l'activité de récepteur .beta.2-adrénergique, ainsi que des procédés utiles de préparation d'un tel composé cristallin.
Jacobsen John R.
Khossravi Davar
Linsell Martin S.
Paborji Mehdi
Zhang Weijiang
Theravance Inc.
Torys Llp
LandOfFree
Crystalline .beta.2 adrenergic receptor agonist does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Crystalline .beta.2 adrenergic receptor agonist, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystalline .beta.2 adrenergic receptor agonist will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1771262